- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04524533
VR Smoking Cessation During a Dental Hygiene Visit
Delivery of a Smoking Cessation Induction Intervention Via Virtual Reality (VR) Headset During a Dental Cleaning: Randomized Controlled Trial
The goal of this randomized controlled trial (RCT) is to test whether a smoking cessation induction intervention delivered during a dental cleaning appointment increases the utilization of evidence-based treatments (EBTs) for smoking cessation within 7 months post-dental cleaning appointment.
Approximately 400 cigarette smokers who are scheduled for a dental cleaning appointment at the Boston University Goldman School of Dental Medicine (BUGSDM) patient treatment center will be recruited and enrolled. Participants will be randomized to either the intervention or control group
Study Overview
Status
Conditions
Detailed Description
Approximately 400 patients who have a scheduled prophylaxis, root planing and scaling dental appointment at the BUGSDM patient treatment center will be recruited and enrolled in the randomized controlled trial. Participants who complete the baseline survey will be randomized to either the intervention or control group. The intervention group will watch one of two smoking cessation videos during the appointment (depending on readiness to quit), receive a brochure about EBTs for smoking cessation, and participate in a 4-week tailored text message program designed to motivate EBT utilization. After the 4-week text message program, the intervention group will receive monthly assessment text messages for six months. The control group will watch a control video during the appointment, receive the same brochure about EBTs as the intervention group, and participate in an assessment-only 4-week text message program. All videos are approximately 10 minutes long.
After the dental clinic appointment, all participants will complete an online questionnaire and begin the 4-week text message program.
At the end of the 4-week text message program, and 3 and 6 months later, all participants will complete online questionnaires.
Primary Aim 1: To test the efficacy of the intervention vs. control in increasing utilization of EBTs over the course of follow-up (7-months). Hypothesis 1.1: Smokers randomized to the intervention will be more likely to engage with (contact) EBTs. Hypothesis 1.2: Smokers randomized to the intervention will have greater treatment utilization (e.g., more days in the text message program, more days using smoking cessation medication, and more quitline counseling sessions, greater number of EBTs).
Secondary Aims:
Aim 2: To test the effect of the intervention vs. controls on quit attempts and on motivation to quit. Hypothesis 2: Smokers randomized to the intervention will have more quit attempts and higher motivation to quit.
Aim 3: To test the efficacy of the intervention vs controls on biochemically verified abstinence. Hypothesis 3: Smokers randomized to the intervention will have higher quit rates at follow-up.
Aim 4: To assess the mechanisms through which the intervention effects occur (social cognitive mediators) and to identify subpopulations for whom intervention effects differ (moderators, e.g., readiness to quit, gender, race/ethnicity). Hypothesis 4: The intervention will directly affect the putative mediators, which will in turn affect EBT utilization. The role of moderators will be exploratory.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Belinda Borrelli, PhD
- Phone Number: 617-358-3358
- Email: belindab@bu.edu
Study Contact Backup
- Name: Romano Endrighi, PhD MSc
- Phone Number: 617-358-6393
- Email: endrighi@bu.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Recruiting
- Henry M Goldman School of Dental Medicine
-
Contact:
- Romano Endrighi, PhD MSc
- Phone Number: 617-358-6393
- Email: endrighi@bu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient of the Boston University, Henry M Goldman School of Dental Medicine treatment center with an upcoming dental hygiene appointment (dental prophylaxis or scaling and root planing)
- Self-reported smoking 100 cigarettes or more (not including e-cigarettes or vaping) in lifetime
- Self-reported smoking any cigarette (not including e-cigarettes or vaping) in the preceding week
- Self-reported cigarettes (not including e-cigarettes or vaping) 'some days', 'most days' or 'every day' in the preceding week
- Is able to understand written and spoken study materials
- Score of 'Never,' 'Rarely' or 'Sometimes' on the validated single-item literacy screener ("How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor, dentist, or pharmacy?")
- Self-reported visual capacity to watch a video as indicated by the score 'Some difficulty' or 'No difficulty' to: "How much difficulty do you have with your vision, even when wearing glasses?"
- Self-reported ability to wear headphones that are inserted partially inside the ear
- Self-reported use of text messaging at least once in the preceding month
- Self-reported access to necessary resources for intervention: Cell phone capable of text messaging
- Live in Massachusetts
- Stated willingness to comply with text message program procedures (receive and respond to text messages for 4-weeks)
Exclusion Criteria:
- Participation in another treatment or intervention study for smoking cessation or research involving text messaging
- Current use of medications for smoking cessation or smoking reduction (nicotine replacement product, or non-nicotine medications) whether prescribed or not
- Failure to complete the pre-dental clinic appointment procedure before the start of the dental appointment (opt-into the text message program and complete the baseline questionnaire)
- Failure to show up to scheduled dental appointment at the clinic
- Previous participation in the pilot phase
- Could not watch video during dental appointment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Participants randomized into the intervention arm will watch smoking cessation videos (ready to quit or not ready to quit) during a dental cleaning clinic visit, receive a brochure about EBTs, and participate in a 4-week text message program which consists of automated and tailored text messages to motivate EBT utilization.
After the 4-week program, the intervention group will receive monthly assessment text messages.
|
Participants who are randomized to the intervention group will watch an educational video that includes tips on quitting smoking during a dental cleaning.
The video is approximately 10 minutes long and tailored to readiness to quit at the time of the dental visit.
All participants will receive identical print materials on EBTs consistent with smoking cessation standard clinical care.
Participants randomized to the intervention group will be enrolled in a 4-week tailored text message program which includes assessment questions in addition to text messages geared towards motivating and facilitating EBT utilization for individuals ready to quit smoking and individuals who are not ready to quit smoking.
|
Active Comparator: Control group
Participants randomized into the control arm will watch a control video during a dental hygiene visit and receive a brochure about EBTs, and a 4-week assessment-only text message program.
|
All participants will receive identical print materials on EBTs consistent with smoking cessation standard clinical care.
Participants randomized to the control group will watch a 10 minute video.
Participants randomized to the control group will be enrolled in a different 4-week text message program that includes only assessment questions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Utilization of Massachusetts State Quitline
Time Frame: 7 months
|
Self-reported use of smoker quitline services validated through objective review of the quitline database (whether participant contacted the quitline, whether a decision to start counseling was made, the type of counseling requested, the number of sessions received, whether a quit date was set, whether nicotine replacement products were requested by participants, and whether nicotine replacement products were sent to participants).
|
7 months
|
Utilization of the National Cancer Institute "SmokefreeTXT" service
Time Frame: 7 months
|
Self-reported use of SmokefreeTXT validated through objective verification of program interaction (length of program utilization, and engagement with program).
|
7 months
|
Utilization of clinic or hospital-based smoking cessation services
Time Frame: 7 months
|
Self-reported use of smoking cessation programs offered by clinics or hospitals (whether participant contacted the clinic, whether a decision to start counseling was made, the type of counseling requested, the number of sessions received, whether a quit date was set, whether nicotine replacement products and/or other cessation medications were requested by participants, and whether nicotine replacement products and/or other cessation medications were given to participants).
|
7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Use of a combination of EBTs
Time Frame: 7 months
|
Self-reported use of at least two EBTs for smoking cessation validated through objective verification of program use.
|
7 months
|
Quit smoking attempts
Time Frame: 7 months
|
Self-reported number of quit smoking attempts lasting 24 hours or more.
|
7 months
|
Motivation to quit smoking
Time Frame: 7 months
|
Self-reported motivation to quit smoking within the following 30 days.
|
7 months
|
7-day point prevalence smoking abstinence at end-of-treatment
Time Frame: 1 month
|
Self-reported smoking abstinence biochemically confirmed with cotinine test.
|
1 month
|
7-day point prevalence smoking abstinence at end-of-treatment
Time Frame: 3 months
|
Self-reported smoking abstinence biochemically confirmed with cotinine test.
|
3 months
|
7-day point prevalence smoking abstinence at end-of-treatment
Time Frame: 6 months
|
Self-reported smoking abstinence biochemically confirmed with cotinine test.
|
6 months
|
Participant's satisfaction
Time Frame: within 10 days after the dental clinic visit.
|
Self-reported satisfaction with overall experience at the dental clinic visit.
|
within 10 days after the dental clinic visit.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Belinda Borrelli, PhD, Henry M Goldman School of Dental Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H-40368
- 4UH3DE028866-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
The University of Hong KongNot yet recruitingSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
Clinical Trials on Experimental smoking cessation video
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingCigarette Smoking-Related CarcinomaUnited States
-
The University of Hong KongCompletedSmoking CessationHong Kong
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); CVS Health FoundationCompletedSmoking | CancerUnited States
-
Oregon Research Behavioral Intervention Strategies...RecruitingTobacco UseUnited States
-
Washington University School of MedicineCompleted
-
University of Missouri, Kansas CityCompleted
-
The University of Hong KongNot yet recruiting
-
ImbioNational Cancer Institute (NCI); Mayo Clinic; University of Michigan; University... and other collaboratorsCompleted
-
Oulu University HospitalActive, not recruiting
-
Kimber Richter, PhD, MPH, MANational Heart, Lung, and Blood Institute (NHLBI)CompletedSmokingUnited States